Pricing Log in Create free account

Passage Bio, Inc. (PASG) vs Palatin Technologies, Inc. (PTN)

Passage Bio, Inc. and Palatin Technologies, Inc. are both Biotechnology companies. Passage Bio, Inc. and Palatin Technologies, Inc. are of similar size ($11.1M and $10.2M). Passage Bio, Inc. has negative trailing earnings, so its P/E is not meaningful; Palatin Technologies, Inc. trades at 12.2×. Passage Bio, Inc. has the higher net margin (0.00% vs −63.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Palatin Technologies, Inc. leads on 7 and Passage Bio, Inc. on 5.

Valuation

Metric PASG PTN Biotechnology median
P/E n/m 12.21 10.26
P/S n/m 1.23 9.18
P/B 2.48 2.43 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.34 n/m 0.65
EV/Sales n/m 0.67 8.98
Earnings yield (329.07%) 8.19% (34.89%)
Free cash flow yield (330.47%) (83.75%) (24.52%)

Profitability

Metric PASG PTN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (65.74%) 0.00%
Net margin 0.00% (63.54%) 0.00%
Free cash flow margin 0.00% (103.07%) 0.00%
Return on equity (169.09%) (877.60%) (50.12%)
Return on assets (69.20%) (142.11%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PASG PTN Biotechnology median
Revenue growth (TTM) — 110.89% 6.26%
EPS growth (last fiscal year) 32.94% 90.80% 29.88%
Revenue growth, 5-year CAGR — 156.83% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PASG PTN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.22 4.61 4.89
Net debt to EBITDA 0.96 0.87 1.01

Dividend

Metric PASG PTN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PASG PTN Biotechnology median
Market cap 11.13m 10.17m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack